#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Alveolar proteinosis Transitional cell carcinoma Adenocarcinoma gastric Anal cancer Non-renal cell carcinoma of kidney Vascular malformation Retinal dystrophy Cutaneous T-cell lymphoma Emphysema Nasopharyngeal cancer Alport's syndrome Fusarium infection Chronic cutaneous lupus erythematosus Paroxysmal nocturnal haemoglobinuria Staphylococcal infection More trials…

    Learn about Rare Diseases

    Paraneoplastic neurological syndrome – Life with Disease Hairy cell leukaemia – Basic Information Optic glioma – Diagnostics Primary mediastinal large B-cell lymphoma – Diagnostics Noonan syndrome – Basic Information Marfan’s syndrome – Diagnostics Behcet’s syndrome Biotinidase deficiency – Life with Disease Chronic granulomatous disease – Diagnostics SAPHO syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bgb-A445 Etuvetidigene Autotemcel Balcinrenone BRENSOCATIB BMS-986470 Odm-208 Clonidine Hydrochloride Pyridoxine CHOLINE ALFOSCERATE Tezacaftor Abiraterone Delandistrogene Moxeparvovec Selumetinib Diroximel Fumarate Emrusolmin Pelareorep Nebivolol Maraviroc Fludrocortisone Eprosartan Mesilate More therapies…

    Learn about Your Condition

    Adrenal insufficiency Neonatal asphyxia Dry mouth Arterial stiffness Agitation postoperative IgA nephropathy Bipolar disorder Colitis ulcerative Enteritis Arthroscopy Diabetic ketoacidosis Coeliac disease Alcohol abuse Urethral valves Bladder cancer recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Adult T-cell lymphoma/leukaemia refractory

  • Study Comparing Duvelisib with Gemcitabine or Bendamustine for Patients with Relapsed or Resistant T Cell Lymphoma Originating from T Follicular Helper Cells

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • DUVELISIB
    • Bendamustine Hydrochloride
    • Gemcitabine Hydrochloride
    Belgium Czechia Denmark France Germany Italy +3
  • Study of Selinexor, Ifosfamide, Etoposide, and Dexamethasone for Patients with Relapsed or Refractory Peripheral T-cell Lymphomas

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Adult T-cell lymphoma/leukaemia
    • Adult T-cell lymphoma/leukaemia recurrent
    • Adult T-cell lymphoma/leukaemia refractory
    Investigated Drugs:
    • Dexamethasone Phosphate
    • Ifosfamide
    • Etoposide
    Italy

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!